(1) The outgoing and incoming responsible pharmacy manager must report in writing to the commission a change in a responsible manager designation within 10 business days of the change.

(2) Unless otherwise specified, when permanently closing a facility, the facility must:

(a) Report to the commission in writing, no later than 30 calendar days prior to closing:

(i) The date the facility will close;

(ii) The names and addresses of the person(s) who shall have custody of the prescription files, bulk compounding records, repackaging records, invoices and controlled substances inventory records of the facility to be closed;

(iii) The names, credential numbers, and addresses of the person(s) who shall acquire any legend drugs from the facility to be closed, if known at the time the notification is filed; and

(iv) The names, credential numbers, and addresses of persons who shall acquire any controlled substances from the facility to be closed, if known at the time the notification is filed.

(b) Provide notification to customers beginning no later than 30 calendar days prior to closing which includes the last day the pharmacy will be open and the last day a transfer may be initiated. Notification shall include:

(i) Posting a closing notice in a conspicuous place in the public area of the pharmacy;

(ii) Informing patients of the closure during prescription pick-up or delivery including a notice with dispensed prescriptions informing patients of their right to request a prescription transfer, if applicable; and

(iii) Public notice in at least one legal newspaper of general circulation in the area served by the pharmacy that meets the qualifications of RCW 65.16.020. The public notice must appear in both the print and digital versions of the legal newspaper, if available.

(c) No later than 15 calendar days after closing:

(i) Return the facility license to the commission;

(ii) Confirm to the commission that all legend drugs were transferred appropriately and provide the names, credential numbers, and addresses of the person(s) to whom the legend drugs were transferred;

(iii) Confirm to the commission that all controlled substances were transferred appropriately and provide a detailed inventory of the drugs transferred and the names, credential numbers, and addresses of the person(s) to whom the controlled substances were transferred;

(iv) Confirm that the DEA registration and all unused DEA 222 forms were returned to the DEA;

(v) Confirm all pharmacy labels and blank prescriptions were destroyed; and

(vi) Confirm all signs and symbols indicating the presence of the pharmacy have been removed.

(3) The commission may conduct an inspection to verify all requirements in subsection (2) of this section have been completed.

(4) A facility shall immediately report to the commission any disasters, accidents and emergencies which may affect the strength, purity, or labeling of drugs, medications, devices or other materials used in the diagnosis or the treatment of injury, illness, and disease.